S&P 500

5.313,41

0,12%

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

FLKS

FLEX PHARMA, INC. (FLKS)

Flex Pharma, Inc.

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:FLKS

1 2 3 4 5 6 7 8 9 10 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
12/11/2019	22h35	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:FLKS	Flex Pharma, Inc.
28/10/2019	13h33	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:FLKS	Flex Pharma, Inc.
28/10/2019	13h01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:FLKS	Flex Pharma, Inc.
22/10/2019	22h23	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:FLKS	Flex Pharma, Inc.
18/09/2019	23h03	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:FLKS	Flex Pharma, Inc.
18/09/2019	22h56	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:FLKS	Flex Pharma, Inc.
16/09/2019	23h16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:FLKS	Flex Pharma, Inc.
14/09/2019	00h32	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:FLKS	Flex Pharma, Inc.
14/09/2019	00h31	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (3/a)	NASDAQ:FLKS	Flex Pharma, Inc.
13/09/2019	12h17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FLKS	Flex Pharma, Inc.
13/09/2019	12h17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FLKS	Flex Pharma, Inc.
13/09/2019	12h16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FLKS	Flex Pharma, Inc.
12/08/2019	14h17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:FLKS	Flex Pharma, Inc.
29/07/2019	23h28	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:FLKS	Flex Pharma, Inc.
29/07/2019	23h28	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:FLKS	Flex Pharma, Inc.
29/07/2019	23h09	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:FLKS	Flex Pharma, Inc.
24/07/2019	22h49	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:FLKS	Flex Pharma, Inc.
24/07/2019	01h54	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:FLKS	Flex Pharma, Inc.
24/07/2019	01h54	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:FLKS	Flex Pharma, Inc.
24/07/2019	01h53	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:FLKS	Flex Pharma, Inc.
24/07/2019	01h50	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:FLKS	Flex Pharma, Inc.
24/07/2019	01h49	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:FLKS	Flex Pharma, Inc.
22/07/2019	23h09	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:FLKS	Flex Pharma, Inc.
18/07/2019	23h06	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:FLKS	Flex Pharma, Inc.
17/07/2019	23h03	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:FLKS	Flex Pharma, Inc.
15/07/2019	22h18	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:FLKS	Flex Pharma, Inc.
15/07/2019	22h16	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:FLKS	Flex Pharma, Inc.
12/07/2019	22h16	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:FLKS	Flex Pharma, Inc.
12/07/2019	22h05	Business Wire	Flex Pharma Announces Approval of all Merger-Related Proposals at Special Meeting	NASDAQ:FLKS	Flex Pharma, Inc.
01/07/2019	21h04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:FLKS	Flex Pharma, Inc.